JK 102 articles written Jeemin Kwon Latest Articles Type 2 Triple Impact: The FDA Approves a Pill That Combines Three Drugs for Type 2 Diabetes new now next Read more Triple Impact: The FDA Approves a Pill That Combines Three Drugs for Type 2 Diabetes Type 1 & Type 2 The Biggest News in Diabetes Technology, Drugs, and Nutrition: Highlights from ADA 2019 new now next Read more The Biggest News in Diabetes Technology, Drugs, and Nutrition: Highlights from ADA 2019 Type 1 & Type 2 ADA 2019: Day 4 and 5 Highlights new now next Read more ADA 2019: Day 4 and 5 Highlights Type 1 & Type 2 ADA 2019: Day 3 Highlights new now next Read more ADA 2019: Day 3 Highlights Type 1 & Type 2 ADA 2019: Day 2 Highlights new now next Read more ADA 2019: Day 2 Highlights Type 1 & Type 2 Eylea Approved by FDA to Treat All Stages of Diabetes-Related Retinopathy new now next Read more Eylea Approved by FDA to Treat All Stages of Diabetes-Related Retinopathy Type 1 & Type 2 ADA Preview! The Sessions We Are Most Excited to See at ADA 2019 new now next Read more ADA Preview! The Sessions We Are Most Excited to See at ADA 2019 Type 1 Exciting DIY Closed-Loop Study Now Recruiting, Including for Omnipod Users! trial watch Read more Exciting DIY Closed-Loop Study Now Recruiting, Including for Omnipod Users! Type 1 & Type 2 Sanofi's Valyou Savings Program Sets Monthly Insulin Price at $99 new now next Read more Sanofi's Valyou Savings Program Sets Monthly Insulin Price at $99 Type 2 Invokana Slows Down Kidney Disease Progression in People with Type 2 Diabetes new now next Read more Invokana Slows Down Kidney Disease Progression in People with Type 2 Diabetes Pages« first ‹ previous 1 2 3 4 5 6 7 8 9 … next › last »
Type 2 Triple Impact: The FDA Approves a Pill That Combines Three Drugs for Type 2 Diabetes new now next Read more Triple Impact: The FDA Approves a Pill That Combines Three Drugs for Type 2 Diabetes
Type 1 & Type 2 The Biggest News in Diabetes Technology, Drugs, and Nutrition: Highlights from ADA 2019 new now next Read more The Biggest News in Diabetes Technology, Drugs, and Nutrition: Highlights from ADA 2019
Type 1 & Type 2 ADA 2019: Day 4 and 5 Highlights new now next Read more ADA 2019: Day 4 and 5 Highlights
Type 1 & Type 2 Eylea Approved by FDA to Treat All Stages of Diabetes-Related Retinopathy new now next Read more Eylea Approved by FDA to Treat All Stages of Diabetes-Related Retinopathy
Type 1 & Type 2 ADA Preview! The Sessions We Are Most Excited to See at ADA 2019 new now next Read more ADA Preview! The Sessions We Are Most Excited to See at ADA 2019
Type 1 Exciting DIY Closed-Loop Study Now Recruiting, Including for Omnipod Users! trial watch Read more Exciting DIY Closed-Loop Study Now Recruiting, Including for Omnipod Users!
Type 1 & Type 2 Sanofi's Valyou Savings Program Sets Monthly Insulin Price at $99 new now next Read more Sanofi's Valyou Savings Program Sets Monthly Insulin Price at $99
Type 2 Invokana Slows Down Kidney Disease Progression in People with Type 2 Diabetes new now next Read more Invokana Slows Down Kidney Disease Progression in People with Type 2 Diabetes
